Evidence map›Paper›PMID 33125095›Full record

ArticleInternational journal of molecular medicine2020

[Corrigendum] Nicorandil protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis.

Fengyun Zhang, Jinjin Cui, Bo Lv, Bo Yu

Abstract readPublished Erratum
In one paragraph

Article in International journal of molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Fengyun ZhangKey Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, P.R. China.
Jinjin CuiKey Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, P.R. China.
Bo LvKey Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, P.R. China.
Bo YuKey Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After the publication of the above article, the authors have realized that Figs. 2 and 4 in their paper were published with incorrect images; regarding Fig. 2, the data featured in Fig. 2A (for the H/SD + Nico 1000 µM panel) were repeated with those featured in Fig. 1C (the 6 h H/SD panel), and the data shown for Bcl-2 in Fig. 4C were selected incorrectly. These errors arose inadvertently as a consequence of misassembling the figures. The revised versions of Figs. 2 and 4, featuring the corrected data panels for the above‑mentioned experiments, are shown on the next page. Note that the revised data shown for these Figures do not affect the overall conclusions reported in the paper. The authors express their gratitude to the Editor of International Journal of Molecular Medicine for allowing them the opportunity to publish this corrigendum, and apologize to the readership for any inconvenience caused. [the original article was published in International Journal of Molecular Medicine 36: 415-423, 2015; DOI: 10.3892/ijmm.2015.2229].

Identifiers

PMID33125095
PMCPMC7595667

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.